Anifrolumab

ATC L04AG11 · 9 markets · 16 records

Anifrolumab 9 markets · 16 records Forms

AU 4 records · 4 strengths

  • 300 mg/2 mLinjectionSAPHNELO also in US·FR
  • 300 mginjectionSAPHNELO anifrolumab 300 mg concentrated injection vial also in ES unknown
  • 120 mginjectionSAPHNELO anifrolumab 120 mg (150 mg/mL) solution for injection in pre-filled pen also in ES unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 2 records · 2 strengths

CA 2 records · 2 strengths

ES 2 records · 2 strengths

MX 2 records · 1 strengths

    2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名SAPHNELO ×2SAPHNELO SC ×1

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    TW 1 records · 1 strengths

    HK 1 records · 1 strengths

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名SAPHNELO CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/2ML ×1

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

        FR 1 records · 1 strengths

        • 300 mg/2 mLinjectionSAPHNELO 300 mg, solution à diluer pour perfusion also in AU·US

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.